መነሻ › ክሮኒክ ሊምፎሳይቲክ ሉኬሚያ › Pennsylvania › Pittsburgh
በPittsburgh፣ PA ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ 10 ጥናቶች በPittsburgh እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Upmc Hillman Cancer Center(Univ of Pittsburgh), Pittsburgh
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
ተሳታዮችን በመፈለግ ላይደረጃ 3
- West Penn Hospital, Pittsburgh
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Pittsburgh
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UPMC Hillman Cancer Center, Pittsburgh
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UPMC Hillman Cancer Center, Pittsburgh
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 2
- AHN Cancer Institute - West Penn Hospital, Pittsburgh
በሌሎች ከተሞች ለክሮኒክ ሊምፎሳይቲክ ሉኬሚያ የሚደረጉ ጥናቶች
- Boston, MA31 ጥናቶች
- Columbus, OH28 ጥናቶች
- Durham, NC27 ጥናቶች
- Washington, DC22 ጥናቶች
- Seattle, WA20 ጥናቶች
- Rochester, MN19 ጥናቶች
- New York City, NY18 ጥናቶች
- Houston, TX17 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Milwaukee, WI15 ጥናቶች
- Chicago, IL14 ጥናቶች
- Cincinnati, OH14 ጥናቶች
በPittsburgh ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር48 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)41 ጥናቶች
- የጡንቻ ካንሰር39 ጥናቶች
- የኮሎሬክታል ካንሰር32 ጥናቶች
- Metastatic Cancer31 ጥናቶች
- ሜላኖማ31 ጥናቶች
- የእንቁላል ካንሰር30 ጥናቶች
- የኤንዶሜትሪየም ካንሰር23 ጥናቶች
- የሳንባ ካንሰር23 ጥናቶች
- የፕሮስቴት ካንሰር23 ጥናቶች
- ስትሮክ22 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ22 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።